Beam Therapeutics Inc. (BEAM) Social Stream
BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BEAM THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 10 | $150 | $85 | $124.333 | $23.76 | 423.29% |
| 2021-12-22 | 10 | $150 | $85 | $121.555 | $23.76 | 411.6% |
| 2022-01-05 | 11 | $150 | $85 | $122.4 | $23.76 | 415.15% |
| 2022-01-10 | 11 | $159 | $85 | $124.5 | $23.76 | 423.99% |
| 2022-02-01 | 10 | $159 | $85 | $124.5 | $23.76 | 423.99% |
| 2022-02-28 | 10 | $159 | $85 | $126.25 | $23.76 | 431.36% |
| 2022-03-01 | 9 | $154 | $85 | $124.625 | $23.76 | 424.52% |
| 2022-05-09 | 8 | $154 | $110 | $130.285 | $23.76 | 448.34% |
| 2022-05-10 | 8 | $154 | $75 | $114.142 | $23.76 | 380.4% |
| 2022-05-11 | 8 | $130 | $75 | $110 | $23.76 | 362.96% |
| 2022-06-08 | 8 | $130 | $75 | $103.142 | $23.76 | 334.1% |
| 2022-06-17 | 9 | $130 | $41 | $95.375 | $23.76 | 301.41% |
| 2022-07-18 | 9 | $130 | $61 | $97.875 | $23.76 | 311.93% |
| 2022-08-10 | 10 | $130 | $61 | $97.875 | $23.76 | 311.93% |
| 2022-09-17 | 10 | $130 | $60 | $90.125 | $23.76 | 279.31% |
| 2022-11-07 | 10 | $130 | $60 | $89.222 | $23.76 | 275.51% |
| 2022-11-08 | 10 | $130 | $60 | $84.666 | $23.76 | 256.34% |
| 2022-12-13 | 11 | $130 | $60 | $82.4 | $23.76 | 246.8% |
| 2022-12-20 | 11 | $130 | $60 | $82.9 | $23.76 | 248.91% |
| 2023-01-06 | 10 | $103 | $60 | $77.222 | $23.76 | 225.01% |
| 2023-01-26 | 10 | $103 | $60 | $76.777 | $23.76 | 223.14% |
| 2023-02-01 | 11 | $103 | $60 | $75.3 | $23.76 | 216.92% |
| 2023-02-08 | 11 | $103 | $60 | $74.3 | $23.76 | 212.71% |
| 2023-03-01 | 12 | $103 | $60 | $74.1 | $23.76 | 211.87% |
| 2023-03-02 | 12 | $105 | $60 | $74.727 | $23.76 | 214.51% |
| 2023-04-11 | 13 | $105 | $37 | $71.583 | $23.76 | 201.28% |
| 2023-05-10 | 14 | $105 | $37 | $71.416 | $23.76 | 200.57% |
| 2023-05-11 | 14 | $105 | $37 | $69 | $23.76 | 190.4% |
| 2023-05-15 | 14 | $105 | $37 | $68.615 | $23.76 | 188.78% |
| 2023-06-06 | 14 | $105 | $37 | $68.461 | $23.76 | 188.14% |
| 2023-08-08 | 14 | $105 | $37 | $67 | $23.76 | 181.99% |
| 2023-08-09 | 14 | $105 | $35 | $65.615 | $23.76 | 176.16% |
| 2023-08-14 | 14 | $105 | $35 | $65.307 | $23.76 | 174.86% |
| 2023-09-07 | 14 | $105 | $35 | $63.23 | $23.76 | 166.12% |
The Trend in the Analyst Price Target
Over the past 38 weeks, BEAM's average price target has gone down $19.17.
BEAM reports an average of 105.15% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-08 | 11 | 130 | 60 | 84.666 | 38.39 | 120.54% |
| 2022-12-20 | 11 | 103 | 60 | 77.666 | 41.59 | 86.74% |
| 2023-01-26 | 10 | 103 | 60 | 76.777 | 43.85 | 75.09% |
| 2023-03-01 | 12 | 103 | 60 | 74.100 | 38.50 | 92.47% |
| 2023-08-14 | 14 | 105 | 35 | 63.230 | 25.22 | 150.71% |
BEAM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 10 | 0 | 4 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
BEAM's average broker recommendation rating improved by 0.55 over the prior 28 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, BEAM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3968.48% of them.
- BEAM THERAPEUTICS INC's average analyst price target is higher than 3765.48% of stocks in the mid market cap category.
- BEAM THERAPEUTICS INC's number of analysts covering the stock is higher than 3472.85% of stocks in the mid market cap category.
- In terms of how BEAM THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -3162.86% of that group.
In the Pharmaceutical Products industry, PLX, EDIT, and FATE are the three stocks most similar to BEAM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BEAM? Use POWR Ratings for clearer insight into price direction.